Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome is a risk factor for the development of diabetes and cardiovascular disease; however, no prospective studies have examined the metabolic syndrome as a risk factor for chronic kidney disease (CKD). A total of 10,096 nondiabetic participants who were in the Atherosclerosis Risk in Communities study and had normal baseline kidney function composed the study cohort. The metabolic syndrome was defined according to recent guidelines from the National Cholesterol Education Program. Incident CKD was defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2 at study year 9 among those with an eGFR > or =60 ml/min per 1.73 m2 at baseline. After 9 yr of follow-up, 691 (7%) participants developed CKD. The multivariable adjusted odds ratio (OR) of developing CKD in participants with the metabolic syndrome was 1.43 (95% confidence interval [CI], 1.18 to 1.73). Compared with participants with no traits of the metabolic syndrome, those with one, two, three, four, or five traits of the metabolic syndrome had OR of CKD of 1.13 (95% CI, 0.89 to 1.45), 1.53 (95% CI, 1.18 to 1.98), 1.75 (95% CI, 1.32 to 2.33), 1.84 (95% CI, 1.27 to 2.67), and 2.45 (95% CI, 1.32 to 4.54), respectively. After adjusting for the subsequent development of diabetes and hypertension during the 9 yr of follow-up, the OR of incident CKD among participants with the metabolic syndrome was 1.24 (95% CI, 1.01 to 1.51). The metabolic syndrome is independently associated with an increased risk for incident CKD in nondiabetic adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933
Laaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916 · cited 3×
“88 cm for women or 102 cm for men, (2) triglycerides 150 mg/dl,”
BackgroundPredictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 702
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Muntner, P., Coresh, J., Smith, J. C., Eckfeldt, J., & Klag, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00165.x · Cited by 667
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
Ford, E. S., & Giles, W. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.575 · Cited by 616
Body mass index and the risk of development of end-stage renal disease in a screened cohort
Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., & Takishita, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00582.x · Cited by 603
Pathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Kopple, J. D., Greene, T., Chumlea, W. C., Hollinger, D., Maroni, B. J., Merrill, D., Scherch, L. K., Schulman, G., Wang, S.-R., & Zimmer, G. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00014.x · Cited by 398
Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults
Chen, J., Muntner, P., Hamm, L. L., Fonseca, V., Batuman, V., Whelton, P. K., & He, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000046029.53933.09 · Cited by 396
Syndrome X and Mortality: A Population-based Study
Trevisan, M., Liu, J., Bahsas, F. B., Menotti, A., & for the Risk Factor and Life Expectancy Research Group (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009572 · Cited by 388
Mykkänen, L., Zaccaro, D. J., Wagenknecht, L. E., Robbins, D. C., Gabriel, M., & Haffner, S. M. (1998) · Diabetes · doi:10.2337/diabetes.47.5.793 · Cited by 379
The Nephrotic Syndrome: A Complication of Massive Obesity
WEISINGER, J. R., KEMPSON, R. L., ELDRIDGE, F. L., & SWENSON, R. S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-440 · Cited by 318
Association between microalbuminuria and the metabolic syndrome: NHANES III
Palaniappan, L. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01009-4 · Cited by 309
Tonelli, M., Moyé, L., Sacks, F. M., Cole, T., & Curhan, G. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068461.45784.2f · Cited by 306
Brancati, F. L. (1997) · JAMA · doi:10.1001/jama.278.23.2069 · Cited by 272
Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease?
Bagby, S. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141965.28037.ee · Cited by 257
Effects of hypertension and dyslipidemia on the decline in renal function
Mänttäri, M., Tiula, E., Alikoski, T., & Manninen, V. (1995) · Hypertension · doi:10.1161/01.hyp.26.4.670 · Cited by 229
Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage
Kamijo, A., Kimura, K., Sugaya, T., Yamanouchi, M., Hase, H., Kaneko, T., Hirata, Y., Goto, A., Fujita, T., & Omata, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00618.x · Cited by 213
Pereira, M. A., Folsom, A. R., McGovern, P. G., Carpenter, M., Arnett, D. K., Liao, D., Szklo, M., & Hutchinson, R. G. (1999) · Preventive Medicine · doi:10.1006/pmed.1998.0431 · Cited by 198
Papp, A. C., Hatzakis, H., Bracey, A., & Wu, K. K. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646519 · Cited by 182
Chronic Renal Failure in Non-Insulin-Dependent Diabetes Mellitus
Humphrey, L. L., Ballard, D., Frohnert, P. P., Chu, C.-P., O'Fallon, W. M., & Palumbo, P. J. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-10-788 · Cited by 180
Verani, R. R. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70230-5 · Cited by 164
Ozanne, S. E., & Hales, C. N. (2003) · Diabetologia · doi:10.1007/s00125-003-1131-7 · Cited by 157
Hoehner, C. M., Greenlund, K. J., Rith-Najarian, S., Casper, M. L., & McClellan, W. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015762.92814.85 · Cited by 150
Eckfeldt, J. H., Chambless, L. E., & Shen, Y.-L. (1994) · PubMed · Cited by 122
Cusumano, A. M., Bodkin, N. L., HANSEN, B. C., Iotti, R., Owens, J. W., Klotman, P. E., & Kopp, J. B. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.36348 · Cited by 92
Effects of IGF-I on renal function in end-stage chronic renal failure
Miller, S. B., Moulton, M. J., O’Shea, M. H., & Hammerman, M. R. (1994) · Kidney International · doi:10.1038/ki.1994.260 · Cited by 64
Whelton, P. K., Perneger, T. V., He, J., & Klag, M. J. (1996) · PubMed · Cited by 64
Vijayan, A., Franklin, S. C., Behrend, T., Hammerman, M. R., & Miller, S. B. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.4.r929 · Cited by 51
Fujikawa, R., Okubo, M., Egusa, G., & Kohno, N. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00241-8 · Cited by 41
Plagemann, A., Rodekamp, E., & Harder, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1446-z · Cited by 27
Sedor, J. R., & Schelling, J. R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050513 · Cited by 13
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Metadata
- Authors
- Kurella, M., Lo, J. C., & Chertow, G. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 2134-2140
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2107279414
- Cited by
- 709
- References
- 43
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 23 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 30 · 2018: 29 · 2017: 24 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 42 · 2012: 42
- FWCI
- 27.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01DK12450)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K12AR047659, K12 AR47659)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, non-diabetic adults, estimated glomerular filtration rate, incident CKD risk, Atherosclerosis Risk in Communities Study, diabetes mellitus, hypertension, cardiovascular risk factors
- MeSH terms
- Chronic Disease, Diabetes Mellitus, Female, Humans, Kidney Diseases, Male, Middle Aged, Risk Factors, Incidence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.